|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1003131132 |
| 003 |
OCoLC |
| 005 |
20231120010216.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170907s2017 maua ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d EBLCP
|d OPELS
|d N$T
|d OCLCF
|d YDX
|d OHS
|d OCLCO
|d MEU
|d DKU
|d UAB
|d OCLCO
|d UPM
|d OCLCO
|d D6H
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d CASUM
|d OCLCO
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 1003254078
|a 1028912886
|a 1030777589
|a 1032686491
|a 1036690812
|
| 020 |
|
|
|a 9780128119235
|q (electronic bk.)
|
| 020 |
|
|
|a 0128119233
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128119228
|
| 020 |
|
|
|z 0128119225
|
| 035 |
|
|
|a (OCoLC)1003131132
|z (OCoLC)1003254078
|z (OCoLC)1028912886
|z (OCoLC)1030777589
|z (OCoLC)1032686491
|z (OCoLC)1036690812
|
| 050 |
|
4 |
|a RC268.4
|b .M57 2017eb
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/4042
|2 23
|
| 245 |
0 |
0 |
|a MiRNA and Cancer /
|c edited by Carlo M. Croce, Paul B. Fisher.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press, is imprint of Elsevier,
|c [2017]
|
| 264 |
|
4 |
|c �2017
|
| 300 |
|
|
|a 1 online resource (xi, 220 pages :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in cancer research ;
|v Volume 135
|
| 546 |
|
|
|a Text in English.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed September 13, 2017).
|
| 505 |
0 |
|
|a Chapter One. MicroRNAs and cancer: a long story for short RNAs -- Chapter Two. The enigma of miRNA regulation in cancer -- Chapter Three. Animal models to study microRNA function -- Chapter Four. Cancer hallmarks and microRNAs: the therapeutic connection -- Chapter Five. microRNAs in cancer susceptibility -- Chapter Six. Role of the tRNA-derived small RNAs in cancer: new potential biomarkers and target to therapy -- Chapter Seven. MicroRNAs and epigenetics.
|
| 650 |
|
0 |
|a Cancer
|x Genetic aspects.
|
| 650 |
|
0 |
|a Cancer genes.
|
| 650 |
|
2 |
|a Neoplasms
|x genetics
|0 (DNLM)D009369Q000235
|
| 650 |
|
2 |
|a Genes, Neoplasm
|0 (DNLM)D052138
|
| 650 |
|
6 |
|a Cancer
|x Aspect g�en�etique.
|0 (CaQQLa)201-0004687
|
| 650 |
|
6 |
|a G�enes du cancer.
|0 (CaQQLa)201-0500298
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer genes
|2 fast
|0 (OCoLC)fst01765208
|
| 650 |
|
7 |
|a Cancer
|x Genetic aspects
|2 fast
|0 (OCoLC)fst00845368
|
| 655 |
|
4 |
|a Internet Resources.
|
| 655 |
|
4 |
|a Index not Present.
|
| 700 |
1 |
|
|a Croce, Carlo,
|e editor.
|
| 700 |
1 |
|
|a Fisher, Paul B.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t MiRNA and Cancer.
|b First edition.
|d Cambridge, MA : Academic Press, is imprint of Elsevier, [2017]
|z 9780128119228
|z 0128119225
|w (OCoLC)974699144
|
| 830 |
|
0 |
|a Advances in cancer research ;
|v v. 135.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/0065230X/135
|z Texto completo
|
| 880 |
0 |
|
|6 505-00/(S
|a Front Cover; miRNA and Cancer; Copyright; Contents; Contributors; Preface; Chapter One: MicroRNAs and Cancer: A Long Story for Short RNAs; References; Chapter Two: The Enigma of miRNA Regulation in Cancer; 1. Introduction; 2. Tumor Suppressor miRs and OncomiRs; 3. Factors Regulating miRNAs; 4. Regulation of the miRNA Biogenesis Pathway; 4.1. AGO Proteins; 4.2. Drosha Proteins; 4.3. DGCR8 Proteins; 4.4. DICER Proteins; 5. Direct (Transcriptional) Regulation; 5.1. c-MYC; 5.2. E2F1; 5.3. p53; 6. Indirect Regulation; 6.1. Nuclear Receptors; 6.2. Epigenetic Control; 6.3. TGF-β Signaling
|
